Since its foundation 15 years ago, Clariness’ mission has been to provide patients with easy access to clinical trials. This lead to the idea to digitalize, raise awareness and build up a community around clinical trials resulting in the patient portal ClinLife.
Clariness is proud to announce that its highly well received Patient´s Voice Conference will take place on March 25th 2021. Due to the pandemic, this year’s event will be held virtually. We hope this will allow even more people to have the opportunity to attend Patient’s Voice Conference.
Clariness believes that education is a key step to success. For the past 7 years, Clariness has supported education projects in a remote village near Sunyani, Ghana.
Clariness is doing its part to support and accelerate the world-wide release of a safe Covid-19 vaccine through its patient recruitment services for clinical trials.
What do patients want from a clinical trial? It can be broadly broken down into three categories, this blog explores these concepts further and also highlights why the patient voice is so important…
Do you want to know what the biggest patient recruitment challenges faced by industry and investigators are? This blog sheds some light on what clinical trial leaders want…
Are you using technology to get the right patient for your study? Read this blog to understand the power of technology and how it can improve your clinical trial recruitment challenges…
How can patient-centricity ensure your planned study is feasible? The answer is simple: patient-centric studies are more feasible because they are attractive, convenient, engaging, and understanding of patient needs…
The volume of international studies is growing, with the market for global clinical trials expected to be worth $65.2 billion by 2025.1 Some of the key drivers of the increased globalization of clinical studies include the expanding R&D investments by drug developers in emerging health markets…
There is a growing interest in therapeutic advancements in genomics medicine, orphan drugs, and precision medicine. This interest has driven the need to generate robust clinical findings that can set a momentum for stakeholder acceptance of newly approved treatments. Yet many clinical trials continue struggle to generate quality trial results as they deal with clinical development inefficiencies and ballooning costs.
Subscribe to our monthly newsletter for pharma news, company insights and free downloads.